Standard BioTools Inc (LAB): Next-Year EPS Estimate 25.64%
As of 2026-05-11, Standard BioTools Inc (LAB) has a next-year EPS growth estimate of 25.64%.
Analyst estimates for LAB have remained steady in the most recent observable window, with next-year EPS growth projected at 25.64%. Current-year growth stands at 13.33%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 25.64%
- EPS growth this year
- 13.33%
- EPS next quarter (est)
- -$0.02
- Last price
- $0.99
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-11 | 25.64% | 13.33% | -$0.02 | $0.99 |
| 2026-05-10 | 25.64% | 13.33% | -$0.02 | $1.02 |
| 2026-05-07 | 25.64% | 13.33% | -$0.02 | $1.00 |
| 2026-05-06 | 25.64% | 13.33% | -$0.02 | $0.97 |
Recent News
- Standard BioTools: Q1 Earnings SnapshotAssociated Press
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Standard BioTools Inc's next-year EPS growth estimate?▾
As of 2026-05-11, Standard BioTools Inc (LAB) has a next-year EPS growth estimate of 25.64%, based on analyst consensus.
What sector and industry does Standard BioTools Inc belong to?▾
Standard BioTools Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LAB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Standard BioTools Inc (LAB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports